EHJ:持续感染致感染性心内膜炎患者死亡率增高

2013-06-27 EHJ dxy

临床实践中,抗生素治疗常常不能有效控制感染性心内膜炎病程,进而导致患者死于心衰、血栓、严重败血症或完全性房室传导阻滞的风险增高。根据欧洲指南,这种不能控制的感染包括持续感染,定义为抗生素治疗7-10天后出现发热和持续性血培养阳性。然而,这个分界有点武断,时间可能更长。来自西班牙的一研究小组近期发现左侧感染性心内膜炎在抗生素治疗开始48-72小时后持续性血培养阳性与患者院内死亡率增高密切相关,发表在

临床实践中,抗生素治疗常常不能有效控制感染性心内膜炎病程,进而导致患者死于心衰、血栓、严重败血症或完全性房室传导阻滞的风险增高。根据欧洲指南,这种不能控制的感染包括持续感染,定义为抗生素治疗7-10天后出现发热和持续性血培养阳性。然而,这个分界有点武断,时间可能更长。来自西班牙的一研究小组近期发现左侧感染性心内膜炎在抗生素治疗开始48-72小时后持续性血培养阳性与患者院内死亡率增高密切相关,发表在《欧洲心脏杂志》上。

本研究受试者为1996年至2011年间692例被诊断为左侧感染性心内膜炎的患者,其中407位在经抗生素治疗开始的48-72小时后重复进行血液培养。我们对比了血培养结果阴性和持续阳性患者的档案。采用多因素logistic回归模型分析明确持续血培养阳性与预后的关系。入院时血培养阳性的256例患者中,其中89例(35%)是持续性血培养阳性的。结果表明持续血培养阳性(OR: 2.1; 95% 可信区间: 1.2-3.6)、年龄(OR: 1.026; 95% 可信区间: 1.007-1.046)、金黄色葡萄球菌感染(OR: 3.3; 95% 可信区间: 1.6-6.6)、心衰(OR: 2.8; 95% 可信区间: 1.6-4.7)和肾衰竭(OR: 2.9; 95% 可信区间: 1.8-4.9)与左侧感染性心内膜炎患者院内死亡率增高独立相关。

持续血培养阳性是左侧感染性心内膜炎患者院内死亡率高发的独立危险因素。因此,治疗该类患者时应该考虑危险分级。由于本课题为回顾性研究,更多地数据支持需要前瞻性研究。

Prognostic role of persistent positive blood cultures after initiation of antibiotic therapy in left-sided infective endocarditis
Aim
Persistent infection is not a scientific evidence-based definition. The guidelines of infective endocarditis (IE) establish a cut-off point of 7–10 days, which is arbitrary and probably too long. Our hypothesis is that persistent positive blood cultures after 48–72 h from the initiation of antibiotic therapy are associated with a worse prognosis in patients with left-sided IE.
Methods and results
We repeated blood cultures after 48–72 h of the initiation of the antibiotic treatment in 407 patients with left-sided IE of a total of 692 episodes consecutively diagnosed from 1996 to 2011. We have compared the profile of patients whose blood cultures became negative and those with persistent positive blood cultures. We performed a multivariate logistic regression model to determine the prognostic implication of persistent positive blood cultures.
Of 256 patients with positive blood cultures at admission, 89 (35%) had persistent positive cultures after 48–72 h from the initiation of the antibiotic treatment. Persistent positive blood cultures (OR: 2.1; 95% CI: 1.2–3.6), age (OR: 1.026; 95% CI: 1.007–1.046), Staphylococcus aureus infection (OR: 3.3; 95% CI: 1.6–6.6), heart failure (OR: 2.8; 95% CI: 1.6–4.7), and renal failure (OR: 2.9; 95% CI: 1.8–4.9) were found to be independently associated with higher in-hospital mortality.
Conclusions
The presence of persistent positive blood cultures is an independent risk factor for in-hospital mortality which doubles the risk of death of patients with left-sided IE. It should be taken into account in the risk stratification of these patients.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1655318, encodeId=336e165531803, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Thu Jun 05 19:48:00 CST 2014, time=2014-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983413, encodeId=c9831983413b8, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Dec 22 23:48:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1708289, encodeId=5c6d1e0828906, content=<a href='/topic/show?id=4c2d3051535' target=_blank style='color:#2F92EE;'>#内膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30515, encryptionId=4c2d3051535, topicName=内膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730431558473, createdName=12498974m61暂无昵称, createdTime=Tue Dec 03 13:48:00 CST 2013, time=2013-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350673, encodeId=61ff13506e38c, content=<a href='/topic/show?id=a32d508e8c3' target=_blank style='color:#2F92EE;'>#心内膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50878, encryptionId=a32d508e8c3, topicName=心内膜炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jun 29 06:48:00 CST 2013, time=2013-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561547, encodeId=fcce156154eb5, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sat Jun 29 06:48:00 CST 2013, time=2013-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567556, encodeId=1368156e55648, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sat Jun 29 06:48:00 CST 2013, time=2013-06-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1655318, encodeId=336e165531803, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Thu Jun 05 19:48:00 CST 2014, time=2014-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983413, encodeId=c9831983413b8, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Dec 22 23:48:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1708289, encodeId=5c6d1e0828906, content=<a href='/topic/show?id=4c2d3051535' target=_blank style='color:#2F92EE;'>#内膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30515, encryptionId=4c2d3051535, topicName=内膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730431558473, createdName=12498974m61暂无昵称, createdTime=Tue Dec 03 13:48:00 CST 2013, time=2013-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350673, encodeId=61ff13506e38c, content=<a href='/topic/show?id=a32d508e8c3' target=_blank style='color:#2F92EE;'>#心内膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50878, encryptionId=a32d508e8c3, topicName=心内膜炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jun 29 06:48:00 CST 2013, time=2013-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561547, encodeId=fcce156154eb5, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sat Jun 29 06:48:00 CST 2013, time=2013-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567556, encodeId=1368156e55648, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sat Jun 29 06:48:00 CST 2013, time=2013-06-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1655318, encodeId=336e165531803, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Thu Jun 05 19:48:00 CST 2014, time=2014-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983413, encodeId=c9831983413b8, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Dec 22 23:48:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1708289, encodeId=5c6d1e0828906, content=<a href='/topic/show?id=4c2d3051535' target=_blank style='color:#2F92EE;'>#内膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30515, encryptionId=4c2d3051535, topicName=内膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730431558473, createdName=12498974m61暂无昵称, createdTime=Tue Dec 03 13:48:00 CST 2013, time=2013-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350673, encodeId=61ff13506e38c, content=<a href='/topic/show?id=a32d508e8c3' target=_blank style='color:#2F92EE;'>#心内膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50878, encryptionId=a32d508e8c3, topicName=心内膜炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jun 29 06:48:00 CST 2013, time=2013-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561547, encodeId=fcce156154eb5, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sat Jun 29 06:48:00 CST 2013, time=2013-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567556, encodeId=1368156e55648, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sat Jun 29 06:48:00 CST 2013, time=2013-06-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1655318, encodeId=336e165531803, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Thu Jun 05 19:48:00 CST 2014, time=2014-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983413, encodeId=c9831983413b8, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Dec 22 23:48:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1708289, encodeId=5c6d1e0828906, content=<a href='/topic/show?id=4c2d3051535' target=_blank style='color:#2F92EE;'>#内膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30515, encryptionId=4c2d3051535, topicName=内膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730431558473, createdName=12498974m61暂无昵称, createdTime=Tue Dec 03 13:48:00 CST 2013, time=2013-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350673, encodeId=61ff13506e38c, content=<a href='/topic/show?id=a32d508e8c3' target=_blank style='color:#2F92EE;'>#心内膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50878, encryptionId=a32d508e8c3, topicName=心内膜炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jun 29 06:48:00 CST 2013, time=2013-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561547, encodeId=fcce156154eb5, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sat Jun 29 06:48:00 CST 2013, time=2013-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567556, encodeId=1368156e55648, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sat Jun 29 06:48:00 CST 2013, time=2013-06-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1655318, encodeId=336e165531803, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Thu Jun 05 19:48:00 CST 2014, time=2014-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983413, encodeId=c9831983413b8, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Dec 22 23:48:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1708289, encodeId=5c6d1e0828906, content=<a href='/topic/show?id=4c2d3051535' target=_blank style='color:#2F92EE;'>#内膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30515, encryptionId=4c2d3051535, topicName=内膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730431558473, createdName=12498974m61暂无昵称, createdTime=Tue Dec 03 13:48:00 CST 2013, time=2013-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350673, encodeId=61ff13506e38c, content=<a href='/topic/show?id=a32d508e8c3' target=_blank style='color:#2F92EE;'>#心内膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50878, encryptionId=a32d508e8c3, topicName=心内膜炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jun 29 06:48:00 CST 2013, time=2013-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561547, encodeId=fcce156154eb5, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sat Jun 29 06:48:00 CST 2013, time=2013-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567556, encodeId=1368156e55648, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sat Jun 29 06:48:00 CST 2013, time=2013-06-29, status=1, ipAttribution=)]
    2013-06-29 liuxiaona
  6. [GetPortalCommentsPageByObjectIdResponse(id=1655318, encodeId=336e165531803, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Thu Jun 05 19:48:00 CST 2014, time=2014-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983413, encodeId=c9831983413b8, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Dec 22 23:48:00 CST 2013, time=2013-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1708289, encodeId=5c6d1e0828906, content=<a href='/topic/show?id=4c2d3051535' target=_blank style='color:#2F92EE;'>#内膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30515, encryptionId=4c2d3051535, topicName=内膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=730431558473, createdName=12498974m61暂无昵称, createdTime=Tue Dec 03 13:48:00 CST 2013, time=2013-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350673, encodeId=61ff13506e38c, content=<a href='/topic/show?id=a32d508e8c3' target=_blank style='color:#2F92EE;'>#心内膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50878, encryptionId=a32d508e8c3, topicName=心内膜炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jun 29 06:48:00 CST 2013, time=2013-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561547, encodeId=fcce156154eb5, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sat Jun 29 06:48:00 CST 2013, time=2013-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567556, encodeId=1368156e55648, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sat Jun 29 06:48:00 CST 2013, time=2013-06-29, status=1, ipAttribution=)]
    2013-06-29 liuxiaona

相关资讯

Circulation:卒中和脑出血对感染性心内膜炎有负面影响

  西班牙一项研究表明,中重度缺血性卒中和脑出血对感染性心内膜炎(IE)转归具有显著负面影响。研究进一步提示了早期适当地抗菌治疗的重要性,且应考虑暂时中断抗凝治疗。论文于5月6日在线发表于《循环》(Circulation)。   此项研究共纳入1345例次左侧IE发作,并对前瞻性采集的资料进行了回顾性分析。利用Cox回归模型分析神经系统并发症和相关死亡的预测变量。   结果显示,共有340例患

NEJM:早期手术与常规治疗对感染性心内膜炎的疗效比较

  背景在感染性心内膜炎的治疗中,手术干预以预防全身栓塞的时机和指征尚存在争议。我们在感染性心内膜炎患者中进行了一项试验,以比较早期手术和常规治疗的临床转归。   方法我们将有左侧感染性心内膜炎、严重瓣膜病、并有巨大赘生物的患者随机分配接受早期手术(37例)或常规治疗(39例)。主要终点是发生在随机分组后6周内的院内死亡以及栓塞事件的复合终点。   结果在随机分组后48 小时内,所有被分配至早